Bruce Japsen

Japan's largest pharmaceutical company, bolstering its operations in the United States, will add two new drugs to its Lincolnshire-based product portfolio. Takeda Pharmaceuticals North America Inc., the U.S. subsidiary of...

The state's largest health insurer saw its profit drop 36 percent last year, due in large part to the expiration of a tax benefit from a past acquisition, the company's...

Despite recent self-policing by physicians to curb cozy relationships with pharmaceutical companies, doctors still have a "rather permissive view" about certain drug industry marketing activities, according to a new study....

Despite deteriorating enrollment in HMOs operating in Illinois, the managed-care industry's financial health improved last year due to higher premiums, according to the industry's most vocal critic in the state....

Resurrection Health Care and a Chicago union trying to organize the Catholic medical-care provider's workers are at odds over a proposal to merge two of the chain's hospitals on the...

The state's largest Medicaid HMO wants to join with another health plan in what could signal a new wave of merger activity in the troubled industry covering Illinois' poor patients...

Several giant drugmakers, including North Chicago-based Abbott Laboratories, are counting on a glitzy new advertising campaign to turn the tide of public opinion in the face of unprecedented attacks on...

Advocate Health Care is in another contract dispute with a large Chicago-area health insurer over payment issues. This time, Advocate, the area's largest provider of medical care, has reached an...

Unlike most earlier AIDS treatments, Abbott Laboratories' popular drug Kaletra is like the Energizer bunny in its ability to keep the deadly HIV virus suppressed for long periods of time....

For the first time in years, the Illinois hospital industry's primary regulatory board will include members from organized labor. Among the new appointees Gov. Rod Blagojevich has made to the...